Literature DB >> 1408547

Risk of sepsis in newborns with severe hyperbilirubinemia.

M J Maisels1, E Kring.   

Abstract

Because bacterial infection is a potential cause of hyperbilirubinemia, some authors suggest that newborns with significant unexplained indirect hyperbilirubinemia should be evaluated for sepsis. We reviewed the charts of 306 newborns admitted to a pediatric ward within 21 days of birth with a diagnosis of indirect hyperbilirubinemia (peak serum bilirubin level 316 +/- 48, range 217 to 498 mumol/L) (18.5 +/- 2.8, 12.7 to 29.1 mg/dL). Ninety percent were fully or partially breast-fed. Sepsis was identified in 0 of 306 newborns (upper 95% confidence limit for the risk of sepsis = 1%). The overwhelming majority of newborns who require readmission to hospital for indirect hyperbilirubinemia are healthy, breast-fed newborns and do not need to be investigated for sepsis. If indirect hyperbilirubinemia is ever the only manifestation of bacteremia or incipient sepsis, it must be a rare event.

Entities:  

Mesh:

Year:  1992        PMID: 1408547

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates.

Authors:  Michael Kaplan; Cathy Hammerman; Hendrik J Vreman; Ronald J Wong; David K Stevenson
Journal:  J Pediatr       Date:  2010-07-02       Impact factor: 4.406

2.  Late onset jaundice and urinary tract infection in neonates.

Authors:  Sedigheh Ghaemi; Reyhaneh Jafari Fesharaki; Roya Kelishadi
Journal:  Indian J Pediatr       Date:  2007-02       Impact factor: 1.967

3.  Early onset conjugated hyperbilirubinemia in newborn infants.

Authors:  Filiz Tiker; Aylin Tarcan; Hasan Kilicdag; Berkan Gurakan
Journal:  Indian J Pediatr       Date:  2006-05       Impact factor: 1.967

4.  Bilirubin levels predict renal cortical changes in jaundiced neonates with urinary tract infection.

Authors:  Ioannis Xinias; Vasiliki Demertzidou; Antigoni Mavroudi; Konstantinos Kollios; Panagiotis Kardaras; Fotis Papachristou; Georgios Arsos; Ioannis Tsiouris
Journal:  World J Pediatr       Date:  2009-01-27       Impact factor: 2.764

5.  Intravenous Immunoglobulin G Treatment in ABO Hemolytic Disease of the Newborn, is it Myth or Real?

Authors:  Serdar Beken; Ibrahim Hirfanoglu; Canan Turkyilmaz; Nilgun Altuntas; Sezin Unal; Ozden Turan; Esra Onal; Ebru Ergenekon; Esin Koc; Yildiz Atalay
Journal:  Indian J Hematol Blood Transfus       Date:  2012-08-28       Impact factor: 0.900

Review 6.  Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop.

Authors:  Ronald J Sokol; Ross W Shepherd; Riccardo Superina; Jorge A Bezerra; Patricia Robuck; Jay H Hoofnagle
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

7.  Cord blood bilirubin and prediction of neonatal hyperbilirubinemia and perinatal infection in newborns at risk of hemolysis.

Authors:  Darjan Kardum; Ivana Serdarušić; Borna Biljan; Krešimir Šantić; Vinko Živković; Martina Kos
Journal:  J Pediatr (Rio J)       Date:  2020-10-10       Impact factor: 2.990

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.